Literature DB >> 20960379

Apoptosis as a mechanism for liver disease progression.

Maria Eugenia Guicciardi1, Gregory J Gores.   

Abstract

Hepatocyte injury is ubiquitous in clinical practice, and the mode of cell death associated with this injury is often apoptosis, especially by death receptors. Information from experimental systems demonstrates that hepatocyte apoptosis is sufficient to cause liver hepatic fibrogenesis. The mechanisms linking hepatocyte apoptosis to hepatic fibrosis remain incompletely understood, but likely relate to engulfment of apoptotic bodies by professional phagocytic cells and stellate cells, and release of mediators by cells undergoing apoptosis. Inhibition of apoptosis with caspase inhibitors has demonstrated beneficial effects in murine models of hepatic fibrosis. Recent studies implicating Toll-like receptor 9 in liver injury and fibrosis are also of particular interest. Engulfment of apoptotic bodies is one mechanism by which the TLR9 ligand (CpG DNA motifs) could be delivered to this intracellular receptor. These concepts suggest therapy focused on interrupting the cellular mechanisms linking apoptosis to fibrosis would be useful in human liver diseases. © Thieme Medical Publishers.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20960379      PMCID: PMC3071245          DOI: 10.1055/s-0030-1267540

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  98 in total

Review 1.  Human caspases: activation, specificity, and regulation.

Authors:  Cristina Pop; Guy S Salvesen
Journal:  J Biol Chem       Date:  2009-05-26       Impact factor: 5.157

Review 2.  Life and death by death receptors.

Authors:  Maria Eugenia Guicciardi; Gregory J Gores
Journal:  FASEB J       Date:  2009-01-13       Impact factor: 5.191

3.  Cell biology: Sent by the scent of death.

Authors:  Christopher Gregory
Journal:  Nature       Date:  2009-09-10       Impact factor: 49.962

Review 4.  Caspase inhibitors for the treatment of hepatitis C.

Authors:  Howard C Masuoka; Maria Eugenia Guicciardi; Gregory J Gores
Journal:  Clin Liver Dis       Date:  2009-08       Impact factor: 6.126

5.  Apoptotic body engulfment by hepatic stellate cells promotes their survival by the JAK/STAT and Akt/NF-kappaB-dependent pathways.

Authors:  Joy X Jiang; Kenichiro Mikami; Senthil Venugopal; Yong Li; Natalie J Török
Journal:  J Hepatol       Date:  2009-05-03       Impact factor: 25.083

6.  JNK1-dependent PUMA expression contributes to hepatocyte lipoapoptosis.

Authors:  Sophie C Cazanave; Justin L Mott; Nafisa A Elmi; Steven F Bronk; Nathan W Werneburg; Yuko Akazawa; Alisan Kahraman; Sean P Garrison; Gerard P Zambetti; Michael R Charlton; Gregory J Gores
Journal:  J Biol Chem       Date:  2009-07-28       Impact factor: 5.157

7.  Fatal hepatitis mediated by tumor necrosis factor TNFalpha requires caspase-8 and involves the BH3-only proteins Bid and Bim.

Authors:  Thomas Kaufmann; Philipp J Jost; Marc Pellegrini; Hamsa Puthalakath; Raffi Gugasyan; Steve Gerondakis; Erika Cretney; Mark J Smyth; John Silke; Razq Hakem; Philippe Bouillet; Tak W Mak; Vishva M Dixit; Andreas Strasser
Journal:  Immunity       Date:  2009-01-16       Impact factor: 31.745

8.  Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance.

Authors:  Michael R Elliott; Faraaz B Chekeni; Paul C Trampont; Eduardo R Lazarowski; Alexandra Kadl; Scott F Walk; Daeho Park; Robin I Woodson; Marina Ostankovich; Poonam Sharma; Jeffrey J Lysiak; T Kendall Harden; Norbert Leitinger; Kodi S Ravichandran
Journal:  Nature       Date:  2009-09-10       Impact factor: 49.962

9.  Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome.

Authors:  Avlin B Imaeda; Azuma Watanabe; Muhammad A Sohail; Shamail Mahmood; Mehdi Mohamadnejad; Fayyaz S Sutterwala; Richard A Flavell; Wajahat Z Mehal
Journal:  J Clin Invest       Date:  2009-01-26       Impact factor: 14.808

10.  CX3CL1/fractalkine shedding by human hepatic stellate cells: contribution to chronic inflammation in the liver.

Authors:  Katia Bourd-Boittin; Laetitia Basset; Dominique Bonnier; Annie L'helgoualc'h; Michel Samson; Nathalie Théret
Journal:  J Cell Mol Med       Date:  2009-05-11       Impact factor: 5.310

View more
  55 in total

1.  The role of death effector domain-containing proteins in acute oxidative cell injury in hepatocytes.

Authors:  Jörn M Schattenberg; Marcus A Wörns; Tim Zimmermann; You-Wen He; Peter R Galle; Marcus Schuchmann
Journal:  Free Radic Biol Med       Date:  2012-03-08       Impact factor: 7.376

2.  ApoptoProteomics, an integrated database for analysis of proteomics data obtained from apoptotic cells.

Authors:  Magnus Ø Arntzen; Bernd Thiede
Journal:  Mol Cell Proteomics       Date:  2011-11-08       Impact factor: 5.911

3.  Role of ceramides in nonalcoholic fatty liver disease.

Authors:  Mangesh Pagadala; Takhar Kasumov; Arthur J McCullough; Nizar N Zein; John P Kirwan
Journal:  Trends Endocrinol Metab       Date:  2012-05-17       Impact factor: 12.015

Review 4.  Molecular mechanisms underlying chemical liver injury.

Authors:  Xinsheng Gu; Jose E Manautou
Journal:  Expert Rev Mol Med       Date:  2012-02-03       Impact factor: 5.600

5.  Protective effect of propofol preconditioning on ischemia-reperfusion injury in human hepatocyte.

Authors:  Yuzhu Zhang; Zhenzhen Chen; Nianhai Feng; Junxia Tang; Xingbo Zhao; Chengxiao Liu; Hongyu Xu; Mengyuan Zhang
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

Review 6.  Extracellular matrix and liver disease.

Authors:  Elena Arriazu; Marina Ruiz de Galarreta; Francisco Javier Cubero; Marta Varela-Rey; María Pilar Pérez de Obanos; Tung Ming Leung; Aritz Lopategi; Aitor Benedicto; Ioana Abraham-Enachescu; Natalia Nieto
Journal:  Antioxid Redox Signal       Date:  2014-01-08       Impact factor: 8.401

7.  Amelioration of carbon tetrachloride-induced cirrhosis and portal hypertension in rat using adenoviral gene transfer of Akt.

Authors:  Gang Deng; Xiang-Jun Huang; Hong-Wu Luo; Fei-Zhou Huang; Xun-Yang Liu; Yong-Heng Wang
Journal:  World J Gastroenterol       Date:  2013       Impact factor: 5.742

8.  c-FLIP maintains tissue homeostasis by preventing apoptosis and programmed necrosis.

Authors:  Xuehua Piao; Sachiko Komazawa-Sakon; Takashi Nishina; Masato Koike; Jiang-Hu Piao; Hanno Ehlken; Hidetake Kurihara; Mutsuko Hara; Nico Van Rooijen; Günther Schütz; Masaki Ohmuraya; Yasuo Uchiyama; Hideo Yagita; Ko Okumura; You-Wen He; Hiroyasu Nakano
Journal:  Sci Signal       Date:  2012-12-18       Impact factor: 8.192

9.  Naofen promotes TNF-α-mediated apoptosis of hepatocytes by activating caspase-3 in lipopolysaccharide-treated rats.

Authors:  Jun-Hua Fan; Guo-Gang Feng; Lei Huang; Guo-Duo Tang; Hai-Xing Jiang; Jing Xu
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

10.  Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection.

Authors:  Etienne Patin; Zoltán Kutalik; Julien Guergnon; Stéphanie Bibert; Bertrand Nalpas; Emmanuelle Jouanguy; Mona Munteanu; Laurence Bousquet; Laurent Argiro; Philippe Halfon; Anne Boland; Beat Müllhaupt; David Semela; Jean-François Dufour; Markus H Heim; Darius Moradpour; Andreas Cerny; Raffaele Malinverni; Hans Hirsch; Gladys Martinetti; Vijayaprakash Suppiah; Graeme Stewart; David R Booth; Jacob George; Jean-Laurent Casanova; Christian Bréchot; Charles M Rice; Andrew H Talal; Ira M Jacobson; Marc Bourlière; Ioannis Theodorou; Thierry Poynard; Francesco Negro; Stanislas Pol; Pierre-Yves Bochud; Laurent Abel
Journal:  Gastroenterology       Date:  2012-07-27       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.